Table 2 Baseline characteristics of the study population and lactose intolerance
Characteristics | Lactose intolerant N = 50(%) | Lactose tolerant N = 146(%) | OR | 95% CI | p-value |
|---|---|---|---|---|---|
Sex: | |||||
Male | 27(23.9) | 86(76.1) | 0.82 | 0.43-1.56 | 0.545 |
Female | 23(27.7) | 60(72.3) | |||
Age in months: | |||||
3-12 | 34(32.4) | 71(67.6) | 2.25 | 1.14-4.42 | 0.018* |
Above 12 | 16(17.6) | 75(82.4) | |||
Birth order: | |||||
First | 18(31.0) | 40(69.0) | 1.49 | 0.75-2.95 | 0.250 |
≥Second | 32(23.2) | 106(76.8) | |||
Immunization status: | |||||
Not up to-date | 39(39.8) | 59(60.2) | 5.23 | 2.48-11.03 | < 0.001* |
Up to-date | 11(11.2) | 87(88.8) | |||
ΔMeasles in the previous 3 months: | |||||
Yes | 18(35.3) | 33(64.7) | 1.90 | 0.94-3.83 | 0.070 |
No | 31(22.3) | 108(77.7) | |||
¶HIV status: | |||||
HIV+ve | 19(29.7) | 45(70.3) | 1.42 | 0.72-2.80 | 0.315 |
HIV-ve | 28(23.0) | 94(77.0) |